SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.08-2.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (6991)2/11/1999 4:47:00 PM
From: Anthony Wong  Read Replies (1) of 9523
 
RESEARCH ALERT- Pfizer price target raised
Thursday February 11, 3:52 pm Eastern Time

CHICAGO, Feb 11 (Reuters) - Gruntal and Co. on Thursday reiterated pharmaceutical company Pfizer Inc. a strong buy and raised its one-year price target to $168 from $140, citing the success of Pfizer's launch of the arthritis drug Celebrex.

--The launch of Celebrex had an extremely high 82,600 prescriptions recorded in its third week on the market, making it the second most successful new drug launch in history behind Pfizer's Viagra, Gruntal said in a research note.

--Also, Pfizer's fourth quarter performance was outstanding from existing products without the benefit of the Celebrex launch in January, Gruntal said.

--The Celebrex launch and these trends should provide Pfizer with the strongest momentum of any drug company into 1999, Gruntal said.

--Shares of Pfizer were up 5-1/4 at 132 in afternoon trade.

biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext